Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory DLBCL, PMBCL and FL3B Pharmaceutical Investing
BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M Life Science Investing
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine Pharmaceutical Investing
Komo Plant Based Foods to be Available for Online Purchase Across the United States through GTFO It's Vegan Life Science Investing
FDA Approves Veklury® for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Pharmaceutical Investing
U.S. FDA Approves Second Indication for SKYRIZI® to Treat Adults with Active Psoriatic Arthritis Pharmaceutical Investing
BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products Life Science Investing
LUMAKRAS® RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER Market News
